BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33129963)

  • 1. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
    Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
    Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
    Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
    Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
    Krsakova E; Cermak A; Fedorko M
    J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
    Cussans A; Somani BK; Basarab A; Dudderidge TJ
    BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
    Ongün S; Aslan G; Avkan-Oguz V
    Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
    Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
    Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
    Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
    Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
    Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies.
    Freitas DMO; Moreira DM
    Arab J Urol; 2019; 17(2):114-119. PubMed ID: 31285922
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of prevention of infectious complications during prostate biopsy].
    Kolontarev K B; Stroganov R V; Pushkar D Y
    Urologiia; 2023 Dec; (6):128-132. PubMed ID: 38156696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.